Table 4.
Antibacterial activity of EtOAc and DCM crude extracts against Candida maltosa, measured as inhibition zones (mm) in the agar diffusion assay.
| Fungal strain | Candida maltosa | |
|---|---|---|
| Freshwater culture | Seawater culture | |
| Mycelium sterilium (KT03) | - | - |
| Aspergillus sp. (KT13) | - | - |
| Unidentified strain (KT15) | - | - |
| Mycelium sterilium (KT19) | - | 13.5 ± 1.3 |
| Lasiodiplodia theobromae (KT26) | - | - |
| Epicoccum nigrum (KT28) | - | - |
| Mycelium sterilium (KT29) | - | 13.6 ± 0.5 |
| Xylaria psidii (KT30) | 22.3 ± 0.5 | - |
| Xylaria psidii (KT30) * | 15.6 ± 0.5 | - |
| Mycelium sterilium (KT31) | 13.5 ± 1.7 | - |
| Mycelium sterilium (KT31) * | 11.0 ± 0.0 | - |
| Mycelium sterilium (KT32) | - | - |
| Coniothyrium sp. (KT33) | - | - |
| Nystatin (50 μg/disc) | 23.4 ± 1.1 | 23.4 ± 1.1 |
Extracts tested 2 mg/6 mm disc; Inhibition zone in mm including disc, expressed as Mean ± SD (n = 4);
-: No inhibition zone measured;
*
Dichloromethane (DCM) extracts.